汤臣倍健(300146) - 2024 Q3 - 季度财报

Financial Performance - Revenue for the reporting period was RMB 1.12 billion, a decrease of 48.76% year-over-year[3] - Net profit attributable to shareholders of the listed company was RMB -22.42 million, a decrease of 106.30% year-over-year[3] - Basic earnings per share were RMB -0.01, a decrease of 104.76% year-over-year[3] - Weighted average return on equity was -0.19%, a decrease of 3.22 percentage points year-over-year[3] - The company achieved revenue of 5.734 billion yuan in the first three quarters of 2024, a year-on-year decrease of 26.33%, and net profit attributable to shareholders of 869 million yuan, a year-on-year decrease of 54.31%[12] - Total revenue for the period was 5.73 billion RMB, a decrease from 7.78 billion RMB in the previous period[18] - Net profit attributable to the parent company was 2.92 billion RMB, compared to 3.57 billion RMB in the previous period[17] - Net profit attributable to parent company shareholders was 868,614,585.23, a decrease compared to the previous period's 1,901,106,952.70[19] - Total comprehensive income was 859,413,572.00, down from 1,874,578,385.67 in the previous period[20] - Basic earnings per share were 0.51, compared to 1.12 in the previous period[20] Assets and Liabilities - Total assets at the end of the reporting period were RMB 13.55 billion, a decrease of 10.24% compared to the end of the previous year[3] - Equity attributable to shareholders of the listed company was RMB 11.33 billion, a decrease of 6.92% compared to the end of the previous year[3] - Trading financial assets at the end of the period were RMB 925.03 million, a decrease of 32.70% compared to the beginning of the year, mainly due to a reduction in financial products[6] - Notes receivable financing at the end of the period were RMB 28.40 million, a decrease of 75.73% compared to the beginning of the year, mainly due to an increase in bank acceptance bill transfers[6] - Inventory balance at the end of the period decreased by 32.79% to 664.78 million yuan, mainly due to sales of goods prepared at the end of last year[7] - Fixed assets balance at the end of the period increased by 111.27% to 1.91 billion yuan, mainly due to the new office building reaching the usable state[7] - Construction in progress balance at the end of the period decreased by 69.24% to 436.57 million yuan, mainly due to the new office building reaching the usable state[7] - Short-term loans balance at the end of the period increased by 100.00% to 550.00 million yuan, mainly due to discounted bills not yet due[7] - Accounts payable balance at the end of the period decreased by 66.04% to 144.88 million yuan, mainly due to reduced procurement and use of acceptance bills[7] - Contract liabilities balance at the end of the period decreased by 67.36% to 359.56 million yuan, mainly due to shipments of goods pre-ordered by customers at the end of last year[7] - Total assets decreased to 13.55 billion RMB from 15.10 billion RMB at the beginning of the period[15] - Total liabilities decreased to 2.18 billion RMB from 2.86 billion RMB at the beginning of the period[16] - Cash and cash equivalents decreased to 2.38 billion RMB from 3.33 billion RMB at the beginning of the period[15] - Trade receivables increased to 318.84 million RMB from 249.12 million RMB at the beginning of the period[15] - Inventory decreased to 664.78 million RMB from 989.07 million RMB at the beginning of the period[15] - Fixed assets increased to 1.91 billion RMB from 905.55 million RMB at the beginning of the period[15] - Total equity attributable to the parent company decreased to 11.33 billion RMB from 12.17 billion RMB at the beginning of the period[17] Cash Flow - Net cash flow from operating activities for the period was RMB 341.03 million, a decrease of 74.66% year-over-year[3] - Operating cash inflow decreased by 31.30% to 5.29 billion yuan, mainly due to reduced sales collections and government subsidies[7] - Net cash flow from operating activities decreased by 74.66% to 341.03 million yuan, mainly due to reduced sales collections[8] - Net cash flow from financing activities changed by 262.88% to -1.24 billion yuan, mainly due to increased dividend payments and stock repurchases[8] - Net increase in cash and cash equivalents changed by 72.80% to -942.85 million yuan, mainly due to reduced sales collections and increased dividend payments[8] - Cash flow from operating activities was 341,030,743.31, a significant decrease from 1,345,960,359.98 in the previous period[21] - Cash flow from investing activities was -42,009,600.52, an improvement from -1,562,647,037.52 in the previous period[22] - Cash flow from financing activities was -1,238,897,431.40, a larger outflow compared to -341,405,836.44 in the previous period[22] - Cash and cash equivalents at the end of the period were 2,380,868,570.36, down from 3,323,717,490.49 at the beginning of the period[22] Revenue Breakdown - The main brand "By-Health" generated revenue of 3.194 billion yuan, down 29.20% year-on-year, while "Jianliduo" revenue was 698 million yuan, down 29.90% year-on-year[12] - Lifespace domestic products revenue was 271 million yuan, down 29.55% year-on-year, and overseas LSG revenue was 684 million yuan, down 11.66% year-on-year (145 million AUD, down 12.42%)[12] - Offline channel revenue was 3.109 billion yuan, down 29.08% year-on-year, and online channel revenue was 2.586 billion yuan, down 23.36% year-on-year[12] - Sales revenue from goods and services was 5,183,722,722.01, down from 7,529,845,205.48 in the previous period[21] Operating Costs and Expenses - Operating costs amounted to 4.80 billion RMB, down from 5.60 billion RMB in the prior period[18] - Payments for goods and services were 1,442,219,038.73, down from 2,224,123,131.27 in the previous period[21] - Payments to employees were 875,638,349.17, an increase from 783,356,624.18 in the previous period[21] Shareholder and Stock Information - The company repurchased 15,736,987 shares, accounting for 0.9252% of total shares, with a total payment of 249.54 million yuan[14] - The company's total share capital increased to 1,700,845,431 shares after 536,668 stock options were exercised[14] - The company granted 14.9 million restricted shares to 36 incentive recipients at a price of 8.60 yuan per share, later adjusted to 7.70 yuan per share[14] - The company holds 15,736,987 shares in its repurchase account, accounting for 0.93% of total shares[9] - The top 10 shareholders include Hong Kong Securities Clearing Company with 30,125,638 shares and E Fund ChiNext ETF with 29,618,018 shares[9] - The CSI 500 ETF held 18,683,367 shares, accounting for 1.10% of total shares, with 1,649,800 shares lent out through securities lending[10] Non-Recurring Items - Non-recurring gains and losses for the reporting period amounted to RMB 1.74 million, primarily due to VAT deductions and financial income[4]